Ledger.Open graph →
SEC Form D · filed September 27, 2016

CONSTELLATION PHARMACEUTICALS INC

Offering
$24.3M
Sold
$24.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Michael R. Cooper · Cambridge, MAExecAnthony A. Evnin · Cambridge, MADirectorTom A. Maniatis · Cambridge, MADirectorPeter A. Svennilson · Cambridge, MADirectorJames E. Audia · Cambridge, MAExecMark A. Goldsmith · Cambridge, MAExec · DirectorMatthias E. Jaffe · Cambridge, MAExecRobert A. Tepper · Cambridge, MADirectorAmol Desai · Lafayette, LADirectorWayne S. Kirk · Vancouver, British Columbia, CanadaExecJared Lowe · Houston, TXDirectorStephen C. O'Meara · Dania Beach, FLExecKenneth Towers · Camana Bay, Grand Cayman, Cayman IslandsExecMark S. Fields · Vancouver, British Columbia, CanadaDirectorJonathan C. Trousdale · Dania Beach, FLExec · DirectorJayendra E. Das · BOSTON, MAExec · DirectorJoseph Kinsella · BOSTON, MADirectorAriel E. Tseitlin · BOSTON, MAExecDale A. Buckwalter · PITTSBURGH, PAExecRobert C. Mcguire · PITTSBURGH, PAExec · DirectorMichael T. Puckett · New Orleans, LADirectorBrad M. Hutensky · Hartford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗